JCP-170 is an inhibitor of ABHD6 that works in a dose-dependent manner. References: Barbara M Grüner, Christopher J Schulze, Dian Yang, Daisuke Ogasawara, Melissa M Dix, Zoe N Rogers, Chen-Hua Chuang, Christopher D McFarland, Shin-Heng Chiou, J Mark Brown, Benjamin F Cravatt, Matthew Bogyo, Monte M Winslow. An in vivo multiplexed small-molecule screening platform. Nature Methods 13, 883–889 (2016) doi:10.1038/nmeth.3992.

纯度：≥98%

CAS：120218-98-6